Article
Polymorphic variants (CYP2C9*3 and CYP2C9*5) and the F114L active site mutation of CYP2C9: effect on atypical kinetic metabolism profiles.
Drug metabolism and disposition: the biological fate of chemicals - 1 Apr 2002
Tracy Timothy S, Hutzler J Matthew, Haining Robert L, Rettie Allan E, Hummel Matthew A, Dickmann Leslie J
Abstract excerpt
CYP2C9 wild-type protein has been shown to exhibit atypical kinetic profiles of metabolism that may affect in vitro-in vivo predictions made during the drug development process. Previous work suggests a substrate-dependent effect of polymorphic variants of CYP2C9 on the rate of metabolism; however, it is hypothesized that these active site amino acid changes will affect the kinetic profile of a drug's metabolism...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
